NLO | European patent and trademark attorneys

Wishing you a bright and prosperous Diwali filled with good health and happiness!  #Diwali #bestwishes

👉 Inspiring presentations and lectures gave insights into the future of drug development and health care applications at Dutch Medicine Days 2024. 💡 Our colleague Barend Bouma shared insights about “drug repurposing programs” that embody the potential to extend therapeutic application of an existing drug molecule to a novel indication, to aid patient groups that currently lack adequate or effective treatment. Developing an existing drug for a new indication may be a faster route to the clinic. Also Barend joined FAST in a noteworthy presentation, where he spoke about “from lab to clinic”. 🔔 Our other colleague Kolja Adamczyk was part of the Scientific Committee of the Dutch Medicines Days 2024, where he contributed in selecting three winners of the so called “Poster Sessions”. PhD students doing innovative research in the field of medicines development presented their interesting research & results. 📽 Have a look at our recap of the inspiring Dutch Medicine Days 2024. . . . #IP #intellectualproperty #pharma #drugrepurposing #clinicaltrials . . . Music credits: Back on 74 – Jungle 

👉 Meet our colleague Anna Daneva. Anna joined NLO as a Trainee patent attorney and was originally trained as a plant molecular biologist. As a former industry R&D scientist, she can provide pragmatic solutions to clients, especially clients representing startup companies. Good luck at NLO!  . . . . Interested in working in IP? Check our website: careers.nlo.eu . . #intellectualproperty #IP #patents

Intellectual Property (IP) as a permanent part of their development process, that is what our client Atlas Copco Group incorporates in all of their projects. Writing patent applications is one thing, but arriving at a definition and expressing the core of the invention is another skill. They often involve NLO in that. Read more about how our clients fit IP in their business strategies in these client interviews: https://lnkd.in/eq_3NkfY

Proud to have been part of the jury during the poster sessions yesterday, it was inspiring to see so much talent and ambition! Special thanks to Kolja Adamczyk 👌

A third-party observation filed after the summons became relevant during oral proceedings, changing the preliminary opinion on #inventive step. How should an #Opposition #Division act in admitting further auxiliary requests? Find out the assessment by the #EPO Board of Appeal in more detail: https://lnkd.in/eDhX8hkJ

Mark your calendars: Barend Bouma will be speaking at the 𝐅𝐈𝐆𝐎𝐍 𝐃𝐮𝐭𝐜𝐡 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞𝐬 𝐃𝐚𝐲𝐬 on October 17th! Barend will cover the 𝐢𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐜𝐞 𝐨𝐟 𝐢𝐧𝐭𝐞𝐥𝐥𝐞𝐜𝐭𝐮𝐚𝐥 𝐩𝐫𝐨𝐩𝐞𝐫𝐭𝐲 (𝐈𝐏) 𝐢𝐧 𝐝𝐫𝐮𝐠 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 during the session 𝘛𝘩𝘦 𝘙𝘰𝘢𝘥 𝘧𝘳𝘰𝘮 𝘚𝘤𝘪𝘦𝘯𝘵𝘪𝘧𝘪𝘤 𝘐𝘥𝘦𝘢 𝘵𝘰 𝘵𝘩𝘦 𝘊𝘭𝘪𝘯𝘪𝘤 (10:00-11:15). This session is an excellent opportunity for anyone involved in bringing scientific discoveries to the market. Alongside other experts, Barend will share insights into navigating the challenges of the drug development process and introduce potential partners and tools to help turn ideas into successful start-up ventures. Don’t miss out on this valuable session—join us at the 𝐃𝐮𝐭𝐜𝐡 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞𝐬 𝐃𝐚𝐲𝐬! Read more about the programme and speakers: https://lnkd.in/eG4Zg54C #DrugDevelopment #IntellectualProperty #DutchMedicinesDays

From October 8th to 10th, Mari Korsten and Kolja Adamczyk had the pleasure of meeting with in-house counsel and private practice experts at the 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞𝐬 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐲 𝐒𝐮𝐦𝐦𝐢𝐭. Over three days of insightful discussions, they've exchanged knowledge and explored the latest trends in global IP strategies, focusing on the pharmaceutical industry and regulatory challenges. #lifesciencesstrategysummit #LifeSciences #PharmaIP

Meet us today during the #Bits & #Chips event in Eindhoven-Best. Stop by our booth #7 to #connect with our team: Ann-Sofie Hallbäck, Marta Alvarez Guede, Bart de Leeuw & Harm van der Heijden. Discover how we can help protect your company's #innovation. We look forward to meeting you there!

What from a literal point of view appears broadening of a granted #claim is not necessarily an extension of the scope of #protection. The scope is to be assessed taking into account the understanding of the skilled person when reading the description and drawings, under Art. 69 EPC and the Protocol on Interpretation of Art. 69 EPC. Read more about the decision of the European Patent Office Board of Appeal about case T 190/21: https://lnkd.in/esTuTwz2 #caselaw #patents